Stockscreener 앱 받기
11.96
2.49%
0.29
Gyre Therapeutics Inc 주식(GYRE)의 최신 뉴스
FY2024 Earnings Forecast for GYRE Issued By Noble Financial - Defense World
Gyre Therapeutics president Ma Songjiang sells $46,280 in stock By Investing.com - Investing.com Canada
Gyre Therapeutics president Ma Songjiang sells $46,280 in stock - Investing.com India
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Exploring High Growth Tech Stocks In The US March 2025 - Simply Wall St
Gyre Therapeutics (NASDAQ:GYRE) Coverage Initiated by Analysts at Noble Financial - Defense World
Gyre therapeutics president Ma Songjiang sells $40,776 in stock - Investing.com
Noble Capital Initiates Coverage on Gyre Therapeutics With Outperform Rating, $20 Price Target - Marketscreener.com
Gyre Therapeutics initiated with an Outperform at Noble Capital - TipRanks
Gyre Therapeutics president Ma Songjiang sells $42,480 in stock - MSN
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up – Still a Buy? - Defense World
Gyre Therapeutics president Ma Songjiang sells $43,560 in stock - Investing.com India
Gyre Therapeutics president Ma Songjiang sells $43,560 in stock By Investing.com - Investing.com South Africa
Gyre Therapeutics president Ma Songjiang sells $44,180 in stock - Investing.com
Contrasting IGM Biosciences (NASDAQ:IGMS) and Gyre Therapeutics (NASDAQ:GYRE) - Defense World
Gyre Therapeutics president Ma Songjiang sells $45,480 in stock By Investing.com - Investing.com South Africa
Gyre Therapeutics president Ma Songjiang sells $45,480 in stock - Investing.com India
Public companies in Gyre Therapeutics, Inc. (NASDAQ:GYRE) are its biggest bettors, and their bets paid off as stock gained 10.0% last week - Simply Wall St
Gyre Therapeutics president Ma Songjiang sells shares for $42,860 - MSN
Gyre Therapeutics (NASDAQ:GYRE) Trading 7.6% HigherShould You Buy? - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 9.1%What's Next? - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $49,380 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells $49,380 in stock - Investing.com
Gyre Therapeutics Faces Revenue Decline Amidst Future Prospects - TipRanks
Gyre therapeutics president Ma Songjiang sells $46,360 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $45,434 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $46,360 in stock By Investing.com - Investing.com Nigeria
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Songjiang Ma Sells 2,000 Shares - MarketBeat
Gyre Therapeutics president sells $45,380 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $45,434 in stock By Investing.com - Investing.com Nigeria
Gyre Therapeutics president Ma Songjiang sells shares totaling $50,020 By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells shares totaling $50,020 - MSN
Insider Selling: Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells 2,000 Shares of Stock - MarketBeat
Songjiang Ma Sells 2,000 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - Armenian Reporter
Gyre therapeutics president Ma Songjiang sells $48,029 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $48,029 in stock By Investing.com - Investing.com Canada
1.39%
0.55%
자본화:
|
볼륨(24시간):